Establishment of brain bank and blood/cerebrospinal fluid-based reference laboratory for diagnosis of dementia
Not Applicable
Recruiting
- Conditions
- Diseases of the nervous system
- Registration Number
- KCT0004695
- Lead Sponsor
- Pusan National University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 115
Inclusion Criteria
Neurodegenerative diseases: Alzheimer's disease, frontotemporal dementia, dementia with lewy bodies, parkinson's disease, multisystematrophy, progressive supranuclear palsy syndrome, corticobasal degeneration syndrome, other neurological and neuropsychiatric diseases, cognitively healthy adults
Exclusion Criteria
no exclusion criteria
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method pathological diagnosis
- Secondary Outcome Measures
Name Time Method clinical diagnosis, demographics, clinical data
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular biomarkers are validated in KCT0004695 for early Alzheimer's and Parkinson's dementia detection?
How do blood/CSF biomarkers in KCT0004695 compare to MRI and cognitive tests for dementia diagnosis accuracy?
Which cerebrospinal fluid proteins correlate with progression in KCT0004695's frontotemporal dementia cohort?
What are the safety profiles of lumbar puncture procedures in Pusan National University Hospital's dementia brain bank study?
What existing FDA-approved biomarker panels for dementia could KCT0004695's reference lab complement or replace?